RGNX - REGENXBIO names new chief executive June, 12 2024 07:17 AM REGENXBIO Inc. 2024-06-12 07:17:07 ET More on Regenxbio Regenxbio: Transforming Gene Therapy With Innovative AAV Treatments, Strong Buy Regenxbio GAAP EPS of -$1.38 misses by $0.11, revenue of $15.62M misses by $7.9M Regenxbio Q1 2024 Earnings Preview Seeking Alpha’s Quant Rating on Regenxbio For further details see: REGENXBIO names new chief executive